Prevalence of type-specific HPV infection in Uruguay

Journal of Medical Virology

Volumn 86, Issue 4, 2014, Pages 647-652

  Berois, Nora ^a   Heard, Isabelle ^b,c   Fort, Zoraida ^d   Alonso, Rafael ^e   Sica, Adela ^e   Moerzinger, Patricia ^a   Rodriguez, Guillermo ^e   Sancho Garnier, Hélène ^f   Osinaga, Eduardo ^a   Favre, Michel ^b  

^a INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

^b INSTITUT PASTEUR   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Ministry of Public Health Uruguay   (Uruguay)

^e Cervical Cancer Prevention Program   (Uruguay)

^f UNIV MONTPELLIER   (France)

Author keywords

Cervical cancer prevention; Cervical cytological samples; Human papillomavirus genotypes

Indexed keywords

CERVICAL CANCER PREVENTION; CERVICAL CYTOLOGICAL SAMPLES; HUMAN PAPILLOMAVIRUS GENOTYPES;

ADULT; AGE FACTORS; AGED; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CYTOLOGICAL TECHNIQUES; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; URUGUAY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84893754591     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23870     Document Type: Article

References (19)

1. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70-79.
2. Berois N, De Cremoux P, Mazal D, Sica A, Cedeira M, Caserta B, Barrios E, Osinaga E, Sastre-Garau X. 2013. Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay. Int J Gynecol Cancer 23:527-532.
3. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. 2010. Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789-1799. doi: 10.1086/657321
4. Ciapponi A, Bardach A, Glujovsky D, Gibbons L, Picconi MA. 2011. Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: Systematic review and meta analysis. PLoS ONE 6:e25493.
5. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S, IARC HPV Prevalence Surveys Study Group. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 366:991-998.
6. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7:453-459.
7. de Sanjosé S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX, Retrospective International Survey and HPV Time Trends Study Group. 2010. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 11:1048-1056.
8. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. 2007. Prevalence of HPV infection among females in the United States. J Am Med Assoc 297:813-819.
9. Ferreccio C, Van De Wyngard V, Olcay F, Domínguez MA, Puschel K, Corvalán AH, Franceschi S, Snijders PJ. 2011. High-risk HPV infection after five years in a population-based cohort of Chilean women. Infect Agent Cancer 6:21.
10. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Meijer CJ, Muñoz N. 2006. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 119:2677-2684.
11. Gravitt PE. 2011. The known unknowns of HPV natural history. J Clin Invest 121:4593-4599.
12. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, Clifford GM. 2012. Human papillomavirus types in 115, 789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int J Cancer 131:2349-2359.
13. Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T. 2008. Population based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 123:1864-1870.
14. Ramas V, Mirazo S, Bonilla S, Mendoza L, Lago O, Basiletti J, González J, Picconi MA, Arbiza J. 2013. Human papillomavirus genotypes distribution in cervical samples from Uruguayan women. J Med Virol 85:845-851. doi: 10.1002/jmv.23479
15. Rodríguez G, Alonso R. 2008. Programa de Prevención del Cáncer de Cuello Uterino en el Uruguay "Dr. Enrique Pouey:" Estrategia y manual de procedimientos. Montevideo: Comisión Honoraria de Lucha Contra el Cáncer, Programa Nacional de Control de Cáncer, Ministerio de. Salud. Pública. p 113.
16. Schiller JT, Castellsagué X, Garland SM. 2012. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30:F123-F138.
17. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 121:621-632.
18. Solomon D, Nayar R, editors. 2004. The system Bethesda for reporting cervical cytology, 2nd edition. New York: Springer, p 208.
19. Villa LL. 2011. HPV prophylactic vaccination: The first years and what to expect from now. Cancer Lett 323:106-112.